ExLibris header image
SFX Logo
Title: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination
Source:

Plos One [1932-6203] Cheng, Cheng yr:2012


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study." AIDS 25.2 (2011): 153-. Link to SFX for this item
2. Asmuth, David M. "Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens." The journal of infectious diseases 201.1 (2009): 132-141. Link to Full Text for this item Link to SFX for this item
3. Robertson, Michael N. "Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial." The Lancet 372 (2008): 1881-1893. Link to SFX for this item
4. McElrath, Danilo J. "HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis." The Lancet 372.9653 (2008): 1894-905. Link to SFX for this item
5. Stephenson, Kathryn E. "Preexisting Adenovirus Seropositivity is Not Associated with Increased HIV-1 Acquisition in Three HIV-1 Vaccine Efficacy Trials." The Journal of infectious diseases 205.12 (2012): 1806-1810. Link to Full Text for this item Link to SFX for this item
6. Glenda, Allen G. "Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study." The Lancet infectious diseases 11.7 (2011): 507-515. Link to SFX for this item
7. Frahm, N. "Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine." The Journal of clinical investigation 122.1 (2012): 359-367. Link to Full Text for this item Link to SFX for this item
8. Koup, R. "Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses." PloS one 5.2 (2010). Link to Full Text for this item Link to SFX for this item
9. Robb, Merlin L. "Failure of the Merck HIV vaccine: an uncertain step forward." Lancet 372.9653 (2008): 1857-1858. Link to SFX for this item
10. Hanke, T. "STEP trial and HIV-1 vaccines inducing T-cell responses." Expert Review of Vaccines 7.3 (2008): 303-9. Link to SFX for this item
11. Barouch, Dan H H. "Adenovirus vector-based vaccines for human immunodeficiency virus type 1." Human gene therapy 16.2 (2005): 149-56. Link to SFX for this item
12. Barouch, Dan H H. "Challenges in the development of an HIV-1 vaccine." Nature 455.7213 (2008): 613-9. Link to Full Text for this item Link to SFX for this item
13. Giri, M. "Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity." Nature 415.6869 (2002): 331-5. Link to Full Text for this item Link to SFX for this item
14. USA, The rgp120 HIV Vaccine Study Group, Neil M M. "Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection." The journal of infectious diseases 191.5 (2005): 654-65. Link to Full Text for this item Link to SFX for this item
15. Haynes, Robin J F. "Critical issues in mucosal immunity for HIV-1 vaccine development." The journal of allergy and clinical immunology 122.1 (2008): 3-9. Link to SFX for this item
16. Kibuuka, H. "A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172)." The journal of infectious diseases 201.4 (2010): 600-607. Link to Full Text for this item Link to SFX for this item
17. Freed, E O O. "HIV-1 replication." Somatic cell and molecular genetics 26.1 (2001): 13-33. Link to Full Text for this item Link to SFX for this item
18. Rerks-Ngarm, S. "Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand." New England Journal of Medicine, The 361.23 (2009): 2209-2220. Link to SFX for this item
19. Milford, C. "Resources and Needs of Research Ethics Committees in Africa: Preparations for HIV Vaccine Trials." IRB 28.2 (2006): 1-9. Link to SFX for this item
20. Coutsinos, Z. "[Designing an effective AIDS vaccine: Strategies and current status.]." La Revue de médecine interne 29.8 (2008): 632-41. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.